Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Lethal infantile mitochondrial myopathy is a rare mitochondrial oxidative phosphorylation disorder characterized by progressive generalized hypotonia, progressive external ophthalmoplegia and severe lactic acidosis, which results in early fatality (days to months after birth). Patients may present with lethargy and areflexia and may associate additional features, such as cardiomyopathy, renal dysfunction, liver involvement and seizures.
Features include: Myopathy, Lethal infantile mitochondrial myopathy, and Lactic acidosis.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Muscles | 2 | Myopathy, Lethal infantile mitochondrial myopathy |
No clinical trials have been registered for lethal infantile mitochondrial myopathy.
1 publication has been identified in PubMed for lethal infantile mitochondrial myopathy. Research spans Basic Science / Preclinical (100%).
Tan NB (2026). [PMID: 41916321](https://pubmed.ncbi.nlm.nih.gov/41916321/). *Am J Hum Genet*. [Basic Science / Preclinical]
Data assembled from 5 of 12 sources · Last updated Sep 19, 2026, 11:55 AM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center